Health Care Select Sector SPDR Fund

Key Points CNBC’s Jim Cramer is taking a more defensive approach as rising oil prices, higher interest rates,…

Insulet is a high-quality compounder where a temporary execution issue is masking strong underlying fundamentals. Type 2 diabetes…

Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just…

Moderna (MRNA) stock doubled on Wednesday and stole the show. But healthcare had already been quietly breaking out…

Treasury Secretary Scott Bessent speaking to CNBC on May 14th, 2026 from Beijing, China. CNBC Hello, this is…

Stocks @ Night is a daily newsletter delivered after hours, giving you a first look at tomorrow and…

CVS Health on Wednesday blew past second-quarter earnings and revenue estimates and raised its 2026 guidance, as its…

The Eli Lilly and Novo Nordisk logos. Mike Blake | Tom Little | Reuters The diverging paths of…

Eli Lilly on Wednesday reported better-than-expected quarterly results and raised its full-year guidance as the company’s portfolio of…

Eli Lilly on Wednesday reported second-quarter earnings and revenue that blew past estimates and hiked its full-year sales outlook,…

Instead of betting on which single pharmaceutical company wins a drug race, West Pharmaceutical Services benefits as the…

The jobs market steps into the spotlight this week, while second-quarter earnings season continues apace. Here’s a closer…

Cramer: Here are 3 defensive stock market moves I’m making as oil and rates surge